Dragonfly Capital’s Premium Top 10 delivered a 58.9 bp weekly gain, using half of the allocated capital. Five of the ten recommended stocks were triggered, with four closed before Friday and Moderna left open. The equal‑weight portfolio outperformed the IWM, SPY, and QQQ benchmarks, and its year‑to‑date return sits at 8.08 %.
Merck (MRK) is consolidating under resistance around $123 within a six‑month uptrend, with bullish RSI, positive MACD and low 1.2% short interest. The stock offers a 2.78% dividend yield and will trade ex‑dividend on March 16, while earnings are slated for...
The latest non‑farm payroll and CPI data left equities in a cautious stance, with the U.S. dollar near a four‑year low and Treasuries flat in a consolidation zone. Gold held steady around $5,000‑$5,100 while crude oil nudged to six‑and‑a‑half‑month highs....